AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
octisalate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| analgesic anti-inflammatory | 4241 | 118-60-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2A,ACVR2B,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,ITK,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK12,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIK3CG,PIM2,PLK1,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ZAP70 | 49 | |||
| kinase-selectivity-class | AXL,BRAF,CDK4,CDK9,EPHB4,GRK2,MAPK7,STK33,TEK,TTK | 10 | |||
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Macular degeneration | 1193.93 | 30.20 | 326 | 7255 | 37644 | 90583222 |
| Chronic sinusitis | 471.52 | 30.20 | 143 | 7438 | 23659 | 90597207 |
| Paraesthesia oral | 431.38 | 30.20 | 143 | 7438 | 31516 | 90589350 |
| Procedural pain | 404.35 | 30.20 | 138 | 7443 | 33222 | 90587644 |
| Vaginal flatulence | 398.13 | 30.20 | 109 | 7472 | 12529 | 90608337 |
| Female genital tract fistula | 395.53 | 30.20 | 117 | 7464 | 17751 | 90603115 |
| Radiculopathy | 378.50 | 30.20 | 114 | 7467 | 18391 | 90602475 |
| Proctitis | 377.80 | 30.20 | 109 | 7472 | 15150 | 90605716 |
| Vaginal discharge | 351.62 | 30.20 | 109 | 7472 | 19355 | 90601511 |
| Oral candidiasis | 287.57 | 30.20 | 109 | 7472 | 35346 | 90585520 |
| Haematochezia | 238.63 | 30.20 | 117 | 7464 | 70796 | 90550070 |
| Colitis ulcerative | 237.99 | 30.20 | 111 | 7470 | 60155 | 90560711 |
| Frequent bowel movements | 237.71 | 30.20 | 109 | 7472 | 56826 | 90564040 |
| Colitis | 228.19 | 30.20 | 113 | 7468 | 69829 | 90551037 |
| Rectal haemorrhage | 224.40 | 30.20 | 118 | 7463 | 82626 | 90538240 |
| Therapeutic product effect incomplete | 210.10 | 30.20 | 154 | 7427 | 193742 | 90427124 |
| Dyspepsia | 176.31 | 30.20 | 140 | 7441 | 198020 | 90422846 |
| Drug ineffective | 154.38 | 30.20 | 348 | 7233 | 1383950 | 89236916 |
| Constipation | 113.39 | 30.20 | 128 | 7453 | 280267 | 90340599 |
| Weight decreased | 110.81 | 30.20 | 147 | 7434 | 379763 | 90241103 |
| Erythema | 110.78 | 30.20 | 115 | 7466 | 229131 | 90391735 |
| Anaemia | 92.94 | 30.20 | 130 | 7451 | 352672 | 90268194 |
| Infusion related reaction | 90.23 | 30.20 | 140 | 7441 | 416640 | 90204226 |
| Pyrexia | 79.49 | 30.20 | 172 | 7409 | 660313 | 89960553 |
| Abdominal pain | 78.81 | 30.20 | 128 | 7453 | 395593 | 90225273 |
| Carbuncle | 67.33 | 30.20 | 17 | 7564 | 1419 | 90619447 |
| Malaise | 65.22 | 30.20 | 148 | 7433 | 585838 | 90035028 |
| Monoclonal immunoglobulin present | 60.73 | 30.20 | 17 | 7564 | 2107 | 90618759 |
| Hypothalamo-pituitary disorder | 59.75 | 30.20 | 17 | 7564 | 2235 | 90618631 |
| Amyloid arthropathy | 50.57 | 30.20 | 14 | 7567 | 1666 | 90619200 |
| Asthma-chronic obstructive pulmonary disease overlap syndrome | 50.52 | 30.20 | 18 | 7563 | 4881 | 90615985 |
| Total lung capacity increased | 50.08 | 30.20 | 18 | 7563 | 5003 | 90615863 |
| Overweight | 47.15 | 30.20 | 18 | 7563 | 5916 | 90614950 |
| Off label use | 47.06 | 30.20 | 199 | 7382 | 1102053 | 89518813 |
| Nasal polyps | 45.85 | 30.20 | 21 | 7560 | 10859 | 90610007 |
| Cholelithiasis | 44.19 | 30.20 | 36 | 7545 | 52470 | 90568396 |
| Nausea | 43.97 | 30.20 | 196 | 7385 | 1110120 | 89510746 |
| Fibrosis | 43.54 | 30.20 | 17 | 7564 | 5935 | 90614931 |
| Wrist deformity | 41.52 | 30.20 | 14 | 7567 | 3224 | 90617642 |
| Hypomania | 40.11 | 30.20 | 18 | 7563 | 8879 | 90611987 |
| Nephropathy | 39.47 | 30.20 | 18 | 7563 | 9217 | 90611649 |
| Jaundice cholestatic | 38.02 | 30.20 | 18 | 7563 | 10025 | 90610841 |
| Sarcoidosis | 36.98 | 30.20 | 18 | 7563 | 10655 | 90610211 |
| Dyslipidaemia | 34.88 | 30.20 | 17 | 7564 | 10090 | 90610776 |
| Bronchiectasis | 34.15 | 30.20 | 22 | 7559 | 22308 | 90598558 |
| Body height decreased | 32.19 | 30.20 | 17 | 7564 | 11932 | 90608934 |
| Proctalgia | 31.98 | 30.20 | 15 | 7566 | 8183 | 90612683 |
| Rhinitis allergic | 31.92 | 30.20 | 19 | 7562 | 16766 | 90604100 |
| Pulmonary pain | 31.82 | 30.20 | 13 | 7568 | 5101 | 90615765 |
| Fatigue | 31.77 | 30.20 | 30 | 7551 | 1153993 | 89466873 |
| Purpura | 31.47 | 30.20 | 18 | 7563 | 14760 | 90606106 |
| Schizophrenia | 31.31 | 30.20 | 18 | 7563 | 14896 | 90605970 |
| Renal cyst | 30.91 | 30.20 | 17 | 7564 | 12933 | 90607933 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Anal inflammation | 163.64 | 22.89 | 34 | 1932 | 2195 | 42617174 |
| SARS-CoV-2 test negative | 153.36 | 22.89 | 31 | 1935 | 1744 | 42617625 |
| Accident | 127.43 | 22.89 | 34 | 1932 | 6469 | 42612900 |
| Proctalgia | 124.50 | 22.89 | 34 | 1932 | 7059 | 42612310 |
| Haemorrhoids | 91.28 | 22.89 | 33 | 1933 | 17064 | 42602305 |
| Body temperature increased | 89.25 | 22.89 | 34 | 1932 | 20324 | 42599045 |
| Febrile neutropenia | 47.22 | 22.89 | 50 | 1916 | 185653 | 42433716 |
| Back pain | 39.27 | 22.89 | 40 | 1926 | 141736 | 42477633 |
| Chills | 36.47 | 22.89 | 32 | 1934 | 94034 | 42525335 |
| Pyrexia | 35.28 | 22.89 | 64 | 1902 | 393978 | 42225391 |
| Neutropenia | 32.80 | 22.89 | 43 | 1923 | 199388 | 42419981 |
| Vomiting | 31.03 | 22.89 | 51 | 1915 | 289672 | 42329697 |
| Pain | 26.04 | 22.89 | 43 | 1923 | 244805 | 42374564 |
| Diarrhoea | 24.97 | 22.89 | 61 | 1905 | 460788 | 42158581 |
| Malaise | 23.54 | 22.89 | 38 | 1928 | 212118 | 42407251 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Macular degeneration | 504.66 | 22.06 | 147 | 8949 | 21512 | 110558691 |
| Chronic sinusitis | 457.79 | 22.06 | 141 | 8955 | 24943 | 110555260 |
| Paraesthesia oral | 416.97 | 22.06 | 141 | 8955 | 33530 | 110546673 |
| Female genital tract fistula | 401.94 | 22.06 | 116 | 8980 | 16403 | 110563800 |
| Vaginal flatulence | 399.43 | 22.06 | 108 | 8988 | 12036 | 110568167 |
| Procedural pain | 390.05 | 22.06 | 136 | 8960 | 35429 | 110544774 |
| Radiculopathy | 371.04 | 22.06 | 113 | 8983 | 19223 | 110560980 |
| Proctitis | 363.95 | 22.06 | 108 | 8988 | 16819 | 110563384 |
| Vaginal discharge | 357.95 | 22.06 | 108 | 8988 | 17800 | 110562403 |
| Oral candidiasis | 261.19 | 22.06 | 108 | 8988 | 44652 | 110535551 |
| Frequent bowel movements | 215.87 | 22.06 | 109 | 8987 | 71281 | 110508922 |
| Colitis ulcerative | 210.45 | 22.06 | 110 | 8986 | 77253 | 110502950 |
| Therapeutic product effect incomplete | 194.69 | 22.06 | 155 | 8941 | 223650 | 110356553 |
| Rectal haemorrhage | 190.45 | 22.06 | 120 | 8976 | 119713 | 110460490 |
| Colitis | 189.51 | 22.06 | 113 | 8983 | 102210 | 110477993 |
| Haematochezia | 189.42 | 22.06 | 118 | 8978 | 115406 | 110464797 |
| Dyspepsia | 180.62 | 22.06 | 139 | 8957 | 190826 | 110389377 |
| Proctalgia | 135.00 | 22.06 | 48 | 9048 | 13174 | 110567029 |
| Anal inflammation | 134.90 | 22.06 | 33 | 9063 | 2463 | 110577740 |
| SARS-CoV-2 test negative | 124.20 | 22.06 | 30 | 9066 | 2123 | 110578080 |
| Constipation | 106.89 | 22.06 | 139 | 8957 | 357647 | 110222556 |
| Weight decreased | 104.39 | 22.06 | 158 | 8938 | 467899 | 110112304 |
| Infusion related reaction | 103.01 | 22.06 | 141 | 8955 | 381021 | 110199182 |
| Pyrexia | 102.99 | 22.06 | 227 | 8869 | 898038 | 109682165 |
| Erythema | 96.14 | 22.06 | 119 | 8977 | 291328 | 110288875 |
| Malaise | 91.10 | 22.06 | 182 | 8914 | 671637 | 109908566 |
| Accident | 86.79 | 22.06 | 33 | 9063 | 10919 | 110569284 |
| Carbuncle | 67.25 | 22.06 | 17 | 9079 | 1450 | 110578753 |
| Anaemia | 64.40 | 22.06 | 140 | 8956 | 546946 | 110033257 |
| Pain | 63.47 | 22.06 | 197 | 8899 | 954758 | 109625445 |
| Abdominal pain | 62.35 | 22.06 | 133 | 8963 | 512856 | 110067347 |
| Monoclonal immunoglobulin present | 58.01 | 22.06 | 17 | 9079 | 2523 | 110577680 |
| Hypothalamo-pituitary disorder | 56.10 | 22.06 | 17 | 9079 | 2829 | 110577374 |
| Total lung capacity increased | 53.85 | 22.06 | 19 | 9077 | 5093 | 110575110 |
| Amyloid arthropathy | 50.80 | 22.06 | 14 | 9082 | 1666 | 110578537 |
| Asthma-chronic obstructive pulmonary disease overlap syndrome | 49.84 | 22.06 | 19 | 9077 | 6325 | 110573878 |
| Haemorrhoids | 47.44 | 22.06 | 32 | 9064 | 35640 | 110544563 |
| Overweight | 45.95 | 22.06 | 18 | 9078 | 6446 | 110573757 |
| Nasal polyps | 45.30 | 22.06 | 22 | 9074 | 13178 | 110567025 |
| Wrist deformity | 41.96 | 22.06 | 14 | 9082 | 3175 | 110577028 |
| Body temperature increased | 41.35 | 22.06 | 35 | 9061 | 54678 | 110525525 |
| Hypomania | 41.12 | 22.06 | 19 | 9077 | 10191 | 110570012 |
| Fibrosis | 39.70 | 22.06 | 17 | 9079 | 7625 | 110572578 |
| Nausea | 39.65 | 22.06 | 203 | 8893 | 1235487 | 109344716 |
| Cholelithiasis | 38.81 | 22.06 | 36 | 9060 | 63386 | 110516817 |
| Sarcoidosis | 37.35 | 22.06 | 19 | 9077 | 12560 | 110567643 |
| Rhinitis allergic | 36.28 | 22.06 | 21 | 9075 | 17901 | 110562302 |
| Jaundice cholestatic | 34.68 | 22.06 | 19 | 9077 | 14589 | 110565614 |
| Body height decreased | 34.44 | 22.06 | 17 | 9079 | 10546 | 110569657 |
| Nephropathy | 30.55 | 22.06 | 17 | 9079 | 13450 | 110566753 |
| Bone density decreased | 30.37 | 22.06 | 18 | 9078 | 16024 | 110564179 |
| Off label use | 29.96 | 22.06 | 218 | 8878 | 1499967 | 109080236 |
| Pulmonary pain | 29.43 | 22.06 | 13 | 9083 | 6280 | 110573923 |
| Bronchiectasis | 28.92 | 22.06 | 24 | 9072 | 36469 | 110543734 |
| Dyspnoea | 27.94 | 22.06 | 30 | 9066 | 1106842 | 109473361 |
| Dyslipidaemia | 27.86 | 22.06 | 17 | 9079 | 15948 | 110564255 |
| Cardiac murmur | 27.84 | 22.06 | 20 | 9076 | 24608 | 110555595 |
| Schizophrenia | 27.64 | 22.06 | 19 | 9077 | 21807 | 110558396 |
| Joint swelling | 26.00 | 22.06 | 3 | 9093 | 442842 | 110137361 |
| Renal cyst | 25.84 | 22.06 | 17 | 9079 | 18155 | 110562048 |
| Fatigue | 24.49 | 22.06 | 39 | 9057 | 1215919 | 109364284 |
| Therapeutic product effect delayed | 23.39 | 22.06 | 10 | 9086 | 4469 | 110575734 |
| Headache | 22.85 | 22.06 | 137 | 8959 | 882240 | 109697963 |
| Toxicity to various agents | 22.28 | 22.06 | 6 | 9090 | 480549 | 110099654 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.9 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 4X49Y0596W | UNII |
| 4025698 | VUID |
| N0000179486 | NUI |
| D05226 | KEGG_DRUG |
| 4020295 | VANDF |
| 4020662 | VANDF |
| 4025698 | VANDF |
| C0304632 | UMLSCUI |
| CHEBI:749764 | CHEBI |
| CHEMBL1329203 | ChEMBL_ID |
| 8364 | PUBCHEM_CID |
| DB11062 | DRUGBANK_ID |
| 7940 | INN_ID |
| 91327 | RXNORM |
| NOCODE | MMSL |
| 006876 | NDDF |
| 29622009 | SNOMEDCT_US |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen | HUMAN OTC DRUG LABEL | 3 | 0023-5494 | LOTION | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 34 Sunscreen (Tinted) | HUMAN OTC DRUG LABEL | 4 | 0023-5497 | LOTION | 30 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Cetaphil Daily Facial Moisturizer with suncreen SPF 35 | HUMAN OTC DRUG LABEL | 4 | 0299-4113 | LOTION | 48 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Cetaphil Healthy Radiance Whipped Day Cream Broad Spectrum SPF 30 | HUMAN OTC DRUG LABEL | 4 | 0299-4118 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Differin Oil Absorbing Moisturizer SPF 30 | HUMAN OTC DRUG LABEL | 3 | 0299-4133 | LOTION | 5 g | TOPICAL | OTC Monograph Drug | 11 sections |
| Cetaphil Oil Absorbing SPF 30 | HUMAN OTC DRUG LABEL | 3 | 0299-4134 | LOTION | 5 g | TOPICAL | OTC Monograph Drug | 10 sections |
| Cetaphil Healthy Renew Day Cream Broad Spectrum SPF 30 | HUMAN OTC DRUG LABEL | 4 | 0299-4136 | LOTION | 48 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Cetaphil Hydrating Face Sunscreen SPF 35 | HUMAN OTC DRUG LABEL | 4 | 0299-4142 | LOTION | 48 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Cetaphil Daily Facial Moisturizer with suncreen SPF 50 | HUMAN OTC DRUG LABEL | 5 | 0299-4930 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Almay Healthy Biome Makeup | HUMAN OTC DRUG LABEL | 5 | 0311-0723 | EMULSION | 5 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Almay Healthy Biome MakeupFair | HUMAN OTC DRUG LABEL | 5 | 0311-0737 | EMULSION | 5 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Almay Healthy Biome MakeupLight | HUMAN OTC DRUG LABEL | 5 | 0311-0738 | EMULSION | 5 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Almay Healthy Biome MakeupMedium | HUMAN OTC DRUG LABEL | 5 | 0311-0739 | EMULSION | 5 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Almay Healthy Biome MakeupGolden | HUMAN OTC DRUG LABEL | 5 | 0311-0740 | EMULSION | 5 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Almay Healthy Biome MakeupTan | HUMAN OTC DRUG LABEL | 5 | 0311-0741 | EMULSION | 5 mg | TOPICAL | OTC Monograph Drug | 9 sections |
| Blue Lizard Kids SPF 50 Sunscreen | HUMAN OTC DRUG LABEL | 3 | 0316-2062 | LOTION | 55.50 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| Blue Lizard Kids SPF 50 Sunscreen | HUMAN OTC DRUG LABEL | 3 | 0316-2062 | LOTION | 55.50 mg | TOPICAL | OTC Monograph Drug | 11 sections |
| Blue Lizard Sport SPF 50 Sunscreen | HUMAN OTC DRUG LABEL | 3 | 0316-2075 | LOTION | 55.50 mg | TOPICAL | OTC Monograph Drug | 10 sections |
| Walgreens SPF 70 Sport Continuous | HUMAN OTC DRUG LABEL | 4 | 0363-0035 | SPRAY | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens SPF 55 Sheer Face Mist Sunscreen | HUMAN OTC DRUG LABEL | 4 | 0363-0053 | SPRAY | 500 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Walgreens SPF 50 Clear Complexion Face Sunscreen | HUMAN OTC DRUG LABEL | 4 | 0363-0066 | LOTION | 45 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens SPF 30 Sport | HUMAN OTC DRUG LABEL | 4 | 0363-0093 | LOTION | 45 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens SPF 50 Sport Continuous Sunscreen | HUMAN OTC DRUG LABEL | 4 | 0363-0128 | SPRAY | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| WALGREENS SPF 100 SHEER BODY SUNSCREEN MIST | HUMAN OTC DRUG LABEL | 4 | 0363-0135 | AEROSOL, SPRAY | 50 mg | TOPICAL | OTC Monograph Drug | 13 sections |
| Walgreens SPF 50 Hydrating | HUMAN OTC DRUG LABEL | 4 | 0363-0136 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens SPF 30 Hydrating | HUMAN OTC DRUG LABEL | 4 | 0363-0146 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens Daily Facial Moisturizer with Broad Spectrum SPF 30 Sunscreen | HUMAN OTC DRUG LABEL | 3 | 0363-0172 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| WALGREENS 100 SHEER BROAD SPECTRUM SPF 100 | HUMAN OTC DRUG LABEL | 4 | 0363-0228 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens 70 Hydrating Sport Broad Spectrum SPF 70 Sunscreen | HUMAN OTC DRUG LABEL | 4 | 0363-0251 | LOTION | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |
| Walgreens 90 Sport Continuous | HUMAN OTC DRUG LABEL | 4 | 0363-0254 | SPRAY | 50 mg | TOPICAL | OTC Monograph Drug | 12 sections |